Saluda Medical, Inc. (ASX:SLD)

Market Cap	320.07M
Revenue	77.46M
Net Income	-146.62M
Shares Out	252.02M
EPS	-0.88
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,347,075
Average Volume	1,782,358
Open	1.900
Previous Close	2.650
Day's Range	1.260 - 1.900
52-Week Range	1.260 - 2.650
Beta	n/a
RSI	n/a
Earnings Date	n/a

About Saluda Medical

Saluda Medical, Inc., a medical device company, develops Evoke, an investigational device for the neuromodulation industry in the United States, Australia, the United Kingdom, and the Netherlands. The company develops a closed-loop spinal cord stimulation system that measures the spinal cord's response to stimulation and adjusts on every pulse to optimize activation within the patient's therapeutic window. It also offers an application to sense, measure, and adjust the pulse. The company was founded in 2011 and is based in Bloomington, Minnesot...

• Industry: Medical, Dental, and Hospital Equipment and Supplies
• Founded: 2011
• Employees: 133
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: SLD